Clinical Trial: Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea

U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT06942156) titled 'Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea' on April 11.

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of lower dose calcineurin inhibitors (CNI) in combination with Everolimus in Korean heart transplant recipients.

Study Start Date: Aug. 14, 2025

Study Type: INTERVENTIONAL

Condition: Heart Transplant

Intervention: DRUG: Everolimus

Up to 1.5g BID(total 3g daily), PO - Check the blood concentration of Everolimus at each visit

DRUG: Mycophenolate mofetil Tablet/Capsule

Up to 1.5g BID(total 3g daily), PO

Recru...